You are here

Transoral Robotik Supraglottik Larenjektomi

Transoral Robotic Supraglottic Laryngectomy

Journal Name:

Publication Year:

DOI: 
10.17954/amj.2016.54
Abstract (2. Language): 
Objective: Transoral robotic surgery (TORS) is a minimally invasive new technique for the endolaryngeal treatment of supraglottic larynx cancers. The aim of this study was to present our initial experiences with transoral robotic supraglottic laryngectomy performed in two cases. Material and Methods: Two patients with early stage (T1-2) supraglottic cancer were selected for TORS. The preoperative, intraoperative and postoperative management of patients were presented with a literature review. Results: Laryngeal tumor tissue was resected en bloc with negative surgical margins in both patients. Patients were extubated on postoperative day one. They were decannulated and started to be fed orally on postoperative day seven. Swallowing functions were recovered completely on postoperative day 10. No perioperative or postoperative complications were observed. The first case was discharged uneventfully on postoperative day 20, and the second case on postoperative day 14. Conclusion: Transoral robotic supraglottic laryngectomy is a safe and effective treatment choice in well–selected patients with supraglottic larynx cancer. Further trials with a larger cohort of patients are needed for evaluation of long-term functional and oncological outcomes.
Abstract (Original Language): 
Amaç: Transoral robotik cerrahi (TORC) supraglottik larenks kanserlerinin endolarengeal tedavisinde minimal invaziv yeni bir yöntemdir. Çalışmanın amacı transoral robotik supraglottik larenjektomi uyguladığımız iki hastadaki ilk tecrübelerimizi paylaşmaktır. Gereç ve Yöntemler: Erken evre (T1-2) supraglottik kanserli iki hasta TORC için seçildi. Hastaların preoperatif, intraoperatif ve postoperatif yönetimi literatür derlemesi eşliğinde sunuldu. Bulgular: Tümörlü larenks dokusu her iki hastada da cerrahi sınırlar negatif halde en-blok rezeke edildi. Hastalar postoperatif birinci günde ekstübe edildiler. Yedinci günde dekanülize edilerek oral beslenmeye başlandılar. Onuncu günde yutma fonksiyonları tamamen düzeldi. Birinci hasta postoperatif 20. gün, ikincisi ise 14. günde sorunsuz taburcu edildi. Perioperatif ve postoperatif komplikasyon izlenmedi. Sonuç: Transoral robotic supraglottik larenjektomi iyi seçilmiş supraglottik larenks kanserli olgularda güvenilir ve etkin bir tedavi seçeneğidir. Uzun dönem fonksiyonel ve onkolojik sonuçlarını değerlendirmek için geniş olgu serilerini içeren ileri araştırmalara ihtiyaç vardır.
113
117

REFERENCES

References: 

1. Chu EA, Kim YJ. Laryngeal cancer: Diagnosis and
preoperative work-up. Otolaryngol Clin North Am 2008;
4:673-95.
2. Morales-Angulo C, Val-Bernal F, Buelta L, Fernandez
F, García-Castrillo L, Rama J. Prognostic factors in
supraglottic laryngeal carcinoma. Otolaryngol Head
Neck Surg 1998; 119:548-53.
3. Agrawal N, Ha PK. Management of early-stage laryngeal
cancer. Otolaryngol Clin North Am 2008; 41:757-69.
4. Back G, Sood S. The management of early laryngeal
cancer: Options for patients and therapists. Curr Opin
Otolaryngol Head Neck Surg 2005;13:85-91.
5. Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon
M, Pinto H, Rosenthal DI, Gillison M, Forastiere AA.
Phase II trial of chemoradiation for organ preservation
in resectable stage III or IV squamous cell carcinomas of
the larynx or oropharynx: Results of Eastern Cooperative
Oncology Group Study E2399. J Clin Oncol 2007;
25:3971-7.
6. Weinstein GS, O’Malley BW Jr, Snyder W, Hockstein
NG. Transoral robotic surgery: Supraglottic partial
laryngectomy. Ann Otol Rhinol Laryngol 2007; 116:19-
23.
7. Park YM, Byeon HK, Chung HP, Choi EC, Kim SH.
Comparison of treatment outcomes after transoral
robotic surgery and supraglottic partial laryngectomy:
Our experience with seventeen and seventeen patients
respectively. Clin Otolaryngol 2013; 38:270-4.
8. Boudreaux BA, Rosenthal EL, Magnuson JS, Newman
JR, Desmond RA, Clemons L, Carroll WR. Robotassisted
surgery for upper aerodigestive tract neoplasms.
Arch Otolaryngol Head Neck Surg. 2009; 135:397-401.
9. Iseli TA, Kulbersh BD, Iseli CE, Carroll WR, Rosenthal
EL, Magnuson JS. Functional outcomes after transoral
robotic Surgery for head and neck cancer. Otolaryngol
Head Neck Surg 2009; 141:166-71.
10. Mendelsohn AH, Remacle M, Van Der Vorst S, Bachy V,
Lawson G. Outcomes following transoral robotic surgery:
Supraglottic laryngectomy. Laryngoscope 2013; 123:208-
14.
11. Remacle M, Hantzakos A, Eckel H, Evrard AS, Bradley
PJ, Chevalier D, Djukic V, de Vincentiis M, Friedrich G,
Olofsson J, Peretti G, Quer M, Werner J. Endoscopic
supraglottic laryngectomy: A proposal for a classification
by the working committee on nomenclature, European
Laryngological Society. Eur Arch Otorhinolaryngol 2009;
266:993-8.
12. Peretti G, Piazza C, Cattaneo A, De Benedetto L, Martin
E, Nicolai P. Comparison of functional outcomes after
endoscopic versus open-neck supraglottic laryngectomies.
Ann Otol Rhinol Laryngol 2006; 115:827-32.
13. Park YM, Kim WS, Byeon HK, Lee SY, Kim SH. Surgical
techniques and treatment outcomes of transoral robotic
supraglottic partial laryngectomy. Laryngoscope 2013;
123:670-7.
14. Kayhan FT, Kaya KH, Sayin I. Transoral robotic
cordectomy for early glottic carcinoma. Ann Otol Rhinol
Laryngol 2012; 121:497-502.
15. Smith RV. Transoral robotic surgery for larynx cancer.
Otolaryngol Clin North Am 2014; 47:379-95.
16. Kayhan FT, Kaya KH, Altintas A, Sayin I. Transoral
robotic supraglottic partial laryngectomy. J Craniofac
Surg 2014; 25:1422-6.
17. Roh JL, Kim DH, Park CI. Voice, swallowing and
quality of life in patients after transoral laser surgery for
supraglottic carcinoma. J Surg Oncol 2008; 98:184-9.
18. Lawson G, Matar N, Remacle M, Jamart J, Bachy V.
Transoral robotic surgery for the management of head and
neck tumors: Learning curve. Eur Arch Otorhinolaryngol
2011; 268:1795-801.

Thank you for copying data from http://www.arastirmax.com